VMRK VIVMARK RESIDENTIAL
Real Estate Investment Trusts · NYSE · SEC CIK 906107 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-13.5%
TTM EPS YoY-13.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR1.7%
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE8.1%
ROA4.2%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets46.3%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.79x
Accruals ratio-3.3%
Payout ratio120.2%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | — |
| SG&A expense | $65.28M | $61.65M | $60.72M | $58.71M | $56.51M |
| Operating income | — | — | $1.16B | $1.12B | $1.68B |
| Interest expense | $306.80M | $285.74M | $269.56M | $282.92M | $272.47M |
| Pretax income | $1.17B | $1.08B | $875.01M | $812.93M | $1.40B |
| Income tax | $1.58M | $1.26M | $1.15M | $900,000 | $915,000 |
| Net income | $1.12B | $1.04B | $835.44M | $776.91M | $1.33B |
| EBITDA | — | — | $2.05B | $2.00B | $2.51B |
| EPS (basic) | 2.95 | 2.73 | 2.20 | 2.06 | 3.56 |
| EPS (diluted) | 2.94 | 2.72 | 2.20 | 2.05 | 3.54 |
| Dividends declared per share | 2.77 | 2.70 | 2.65 | 2.50 | — |
| Weighted avg. shares (diluted) | 390.41M | 390.74M | 390.90M | 389.45M | 388.09M |
| Balance sheet | |||||
| Cash & equivalents | $55.90M | $62.30M | $50.74M | $53.87M | $123.83M |
| Total assets | $20.75B | $20.83B | $20.03B | $20.22B | $21.17B |
| Long-term debt | $8.24B | $8.19B | $7.46B | $7.49B | $8.42B |
| Total debt | $8.24B | $8.19B | $7.46B | $7.49B | $8.42B |
| Total liabilities | $9.34B | $9.25B | $8.46B | $8.52B | $9.48B |
| Shareholders' equity | $11.04B | $11.04B | $11.09B | $11.17B | $10.95B |
| Net debt | $8.19B | $8.13B | $7.41B | $7.44B | $8.30B |
| Shares outstanding | 377.81M | 379.48M | 379.29M | 378.43M | 375.53M |
| Cash flow statement | |||||
| Operating cash flow | $1.65B | $1.57B | $1.53B | $1.45B | $1.26B |
| Investing cash flow | -$321.36M | -$1.18B | -$409.50M | $107.79M | -$434.62M |
| Financing cash flow | -$1.33B | -$376.95M | -$1.12B | -$1.79B | -$565.06M |
| Depreciation & amortization | $1.01B | $952.19M | $888.71M | $882.17M | $838.27M |
| Stock-based compensation | $32.21M | $31.29M | $31.82M | $29.51M | $27.81M |
| Dividends paid | $1.05B | $1.02B | $990.15M | $931.78M | $900.47M |
| Share buybacks | $280.72M | $38.47M | $49.10M | — | — |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.